Federal Trade Commission v. K W Technology Inc.

CourtDistrict Court, E.D. New York
DecidedAugust 25, 2025
Docket1:23-cv-06633
StatusUnknown

This text of Federal Trade Commission v. K W Technology Inc. (Federal Trade Commission v. K W Technology Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Federal Trade Commission v. K W Technology Inc., (E.D.N.Y. 2025).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ----------------------------------------------------------X FEDERAL TRADE COMMISSION,

Plaintiff,

-against- ORDER 23 CV 6633 (MKB) (CLP) KW TECHNOLOGY INC., et al.,

Defendants. ----------------------------------------------------------X POLLAK, United States Magistrate Judge:

On September 6, 2023, the Federal Trade Commission (the “FTC” or “plaintiff”) commenced this action against defendants KW Technology Inc. (“KW”), KW Technology NV Inc. (“KW NV”), Gary Kong, and Timothy Wetzel, individually and as a chief executive officer and chief technology officer of KW and co-owner of KW NV,1 alleging violations of Sections 5(a)(1), 5(m)(1)(A), 12, 13(b), 16(a)(1), and 19 of the Federal Trade Commission Act (“FTC Act”), 15 U.S.C. §§ 45(a)(1), 45(m)(1)(A), 52, 53(b), 56(a)(1), and 57(b), and Section 1401 of the COVID-19 Consumer Protection Act of the 2021 Consolidated Appropriations Act (“CCPA”), Pub. L. No. 116-260, 134 Stat. 1182, 3275-76 (2020). (ECF No. 1). Among other things, the Complaint sought injunctive and monetary relief, along with civil penalties, based on allegations that defendants had engaged in unfair or deceptive acts or practices in connection with the sale of the 1 Virus Buster Invisible Mask, and disseminated false advertisements for the purpose of inducing the purchase of such devices in violation of the FTC Act and the CCPA. (Id.)

1 On October 24, 2023, defendants KW, KW NV, and Gary Kong entered into a Stipulated Order for Permanent Injunction, Monetary Judgment, Civil Penalty Judgment, and Other Relief, and were dismissed from the case. (ECF No. 15). Currently pending before this Court, on referral from the Honorable Margo K. Brodie, is defendant Wetzel’s motion to dismiss based upon his medical conditions that make it difficult for him to participate in the ongoing litigation. (ECF No. 35). Also pending before this Court is a separate motion filed by defendant Wetzel, seeking sanctions against plaintiff’s counsel for

alleged “repeated and improper conduct in this case.” (ECF No. 37 at 1). For the reasons set forth below, it is respectfully recommended that defendant’s motions be denied. FACTUAL AND PROCEDURAL BACKGROUND According to the Complaint, defendants marketed their “Invisible Mask” during the COVID-19 Pandemic, advertising it as a badge to be worn around the neck or on a lapel. (ECF No. 1 ¶ 2). Using websites, social media accounts, and YouTube, defendants claimed that by creating an invisible three-foot barrier, the Invisible Mask could prevent up to 98% of infections from COVID-19 and other viruses, bacteria, allergens, and pathogens. (Id. ¶¶ 2-3). Defendants also claimed that various government agencies, such as the EPA and FDA, had approved the Invisible Mask or its materials, and even advertised using a fake “Certificate of Registration.”

(Id. ¶ 6). The FTC alleges that although defendants claimed to have scientific evidence to back these assertions, defendants lacked any competent or reliable scientific evidence that the Invisible Mask could prevent COVID-19. (Id. ¶ 3). In July 2020, the FTC informed defendants that their claims about the Invisible Mask were unsubstantiated and deceptive and warned them to cease making such claims, a warning that defendants “blatantly ignored.” (Id. ¶¶ 4, 5). Based on a price of $29.99, the FTC alleges that defendants generated at least $100,000 in gross revenues between March 2020 and September 6, 2023, the date the Complaint was filed. (Id. ¶ 7). Prior to filing suit, the FTC engaged in settlement discussions with defendant Wetzel, but he indicated that he was seeking counsel to review any proposed final order. (ECF No. 31 ¶ 2). When he had not retained counsel, the FTC filed suit, and on December 21, 2023, defendant Wetzel, proceeding pro se, filed an Answer to the Complaint. (ECF No. 17). Thereafter, the

Court held several conferences in an effort to assist the parties in reaching a settlement. Although defendant Wetzel initially indicated a willingness to consider a settlement, he indicated that he was seeking counsel’s advice on certain provisions and that he had an attorney who was going to work with him. (ECF No. 31 ¶¶ 4, 5, 7). In July 2024, settlement discussions broke down, with the defendant requesting certain documents from the FTC. (Id. ¶ 5). The Court granted that request and directed plaintiff to provide documents relating to Wetzel’s involvement in the alleged scheme, which the FTC provided. (Id. ¶ 6). However, by “Motion for Delay,” dated August 30, 2024, defendant Wetzel requested a 90-day stay in the proceedings due to certain medical conditions that made it difficult for him to walk more than a few feet and medications that impaired his cognitive functions. (ECF No. 30).

The FTC filed an opposition to the Motion, arguing that it was “yet another delay tactic . . . to avoid settlement or litigation.” (ECF No. 31 ¶ 1). On September 17, 2024, this Court Ordered defendant by October 1, 2024, to supplement his request with a letter from his doctor, confirming his health status. (ECF No. 32). On October 9, 2024, when defendant Wetzel had failed to file a doctor’s note by the deadline set by the Court, the Court, sua sponte, extended the deadline to October 21, 2024 for defendant to file the doctor’s note. (ECF No. 33). Rather than provide a doctor’s letter, defendant, proceeding pro se, filed the pending Motion to Dismiss and Notice of Change of Address on October 31, 2024. (ECF No. 35). That same day, the Court ordered defendant to supply a doctor’s note in connection with the motion to dismiss by November 8, 2024. (ECF No. 36). On November 11, 2024, instead of supplying a doctor’s note, defendant submitted a second pro se motion, this time seeking sanctions against plaintiff’s counsel. (ECF No. 37). DISCUSSION

A. Motion to Dismiss Federal Rule of Civil Procedure 12(b) details how defenses to a claim are to be asserted, including defenses based on lack of subject-matter jurisdiction, lack of personal jurisdiction, improper venue, insufficient process, insufficient service, failure to state a claim, and failure to join a party under Rule 19. Fed. R. Civ. P. 12(b)(1)–(7). The Rule provides that a “motion asserting any of these defenses must be made before pleading if a responsive pleading is allowed.” Fed. R. Civ. P. 12(b). In moving to dismiss, defendant Wetzel does not rely on any of these stated defenses, instead asserting that due to his health conditions, he seeks “compassionate consideration for dismissal of the complaint as a measure to reduce stress and assist in his healing.” (ECF No. 35 at 2). Apart from the fact that the Federal Rules do not provide a basis for dismissal of a

complaint on the basis of a defendant’s health, the FTC objects to his request for dismissal, arguing that it is not only procedurally untimely given that his answer was filed more than a year ago, but it also lacks a legal basis to support dismissal. (ECF No. 40 at 4-5).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Caidor v. Onondaga County
517 F.3d 601 (Second Circuit, 2008)
City of New York v. B.L. Jennings, Inc.
219 F.R.D. 255 (E.D. New York, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Federal Trade Commission v. K W Technology Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/federal-trade-commission-v-k-w-technology-inc-nyed-2025.